RAPLEMOMERAN
UNII 63RW2LFY95

Substance Identification & Data

This profile provides standardized clinical and technical data for Raplemomeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 63RW2LFY95.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3024099-62-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

63RW2LFY95

CAS Registry Number

3024099-62-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RAPLEMOMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224780

National Cancer Institute reference terminology for clinical and research data.

INN ID

13617

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Raplemomeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RAPLEMOMERAN

Common Names & Synonyms

RAPLEMOMERAN [INN]

RNA (RECOMBINANT 5'-(1,2-(M7GM-(5'->5')-P-(P(R))-SP-P-G))-CAPPED HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I .ALPHA. CHAIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED HUMAN PAPILLOMAVIRUS 16 E7 PROTEIN TRANSGENE PLUS TETANUS TOXOID T HELPER EPITOPE P2P16 PLUS HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I TRAFFICKING AND CYTOPLASMIC DOMAIN-SPECIFYING PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER RBL016.2), INNER SALT

External Clinical & Regulatory Resources

Previous UNII63RUQ95KWE

Next UNII63S12P0W7W